ArticleHealth promotion international2025
Policy implementation learnings from the introduction of a mandatory alcohol pregnancy warning label.
Article in Health promotion international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Policy makers lack guidance on effective ways to introduce alcohol warnings, making it important to document the experiences of early adopter countries. Aims of this study were to (i) assess uptake of a mandated pregnancy warning label in Australia, (ii) identify the placement of the warning on products (i.e. front, back, side, top, or bottom), and (iii) compare the results for (i) and (ii) between 2023 and 2024 to provide insights into industry willingness to engage with the policy. In-store visits and web-scraping were used to capture product images that were coded for presence and location of the mandatory pregnancy warning (2023: n = 5923; 2024: n = 6666). Four years after the initial introduction of the policy, corresponding to 1 year after the end of the implementation transition period, 22% of assessed products did not display the mandatory pregnancy warning. In both 2023 and 2024, prevalence was lowest in the spirits category and among single unit and imported products. In most instances, warnings were located on the back of products, although a substantial proportion of multi-packs displayed the warning on the underneath panel of the packaging. The Australian experience offers important insights for other jurisdictions introducing health warnings on alcohol products. Clearly specified compliance deadlines and requirements for warning location could overcome the identified implementation issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.